Clinical trial
Stroke Prevention in Sickle Cell Anemia (STOP 2)
NCT00006182 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00006182 |
|---|---|
| Title | Stroke Prevention in Sickle Cell Anemia (STOP 2) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Blood Disease, Cerebrovascular Accident, Anemia, Sickle Cell |
| Intervention type | Procedure |
| Interventions | Blood Transfusion |
| Start date | Jul 1, 2000 |
| Completion | Feb 1, 2006 |
| First posted | Aug 22, 2000 |
| Last update posted | Feb 18, 2016 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: